| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
Revenue  | 15 | 17 | 17 | 8 | 6 | 7 | 6 | 1 | 1 | 0 | 0 | 0 |
| Expenses | 14 | 17 | 16 | 7 | 5 | 10 | 7 | 1 | 1 | 0 | 0 | 0 |
| EBITDA | 1 | 1 | 1 | 1 | 1 | -3 | -0 | -0 | 0 | -0 | 0 | 0 |
| Operating Profit % | 6 % | 3 % | 7 % | 11 % | 11 % | -51 % | -4 % | -40 % | 0 % | 0 % | 0 % | 0 % |
| Depreciation | 1 | 0 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 0 | -4 | -1 | 1 | -4 | -0 | -0 | -0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 |
| Net Profit | 0 | 0 | 0 | 0 | 0 | -4 | -1 | 1 | -4 | -0 | -0 | -0 |
| EPS in ₹ | 0.04 | 0.02 | 0.01 | 0.00 | 0.05 | -6.45 | -2.19 | 1.23 | -7.24 | -0.46 | -0.21 | 0.00 |
Adline Chem Lab
Adline Chem Lab
9.66
-9.66
(-100.00%)
Key Fundamentals
Market Cap
5.70 Cr
EPS
-0.21
PE Ratio
-161.00
Dividend Yield
0.00 %
Industry
Healthcare 52 Week High
23.75
52 Week Low
9.40
PB Ratio
-3.50
Debt to Equity
0.00
Sector
Pharmaceuticals Actual
Company News
View All News
Adline Chem Lab Limited announced significant board changes during its November 12, 2025 meeting. Sarang Pathak resigned from his position as Executive Director-Chairman (Managing Director) and Hemant Parikh stepped down as Non-Executive Promoter Director, both effective from the close of business on November 12, 2025. The company appointed Vrushank Patel as the new Chairman of the Board and authorized him to handle necessary documentation and approvals. The board also approved unaudited standalone financial results for the quarter and half-year ended September 30, 2025, along with noting the statutory auditors' limited review report. The company's cash and cash equivalents increased to 7.36 from 6.32 in the previous period, while it reported a loss before tax of 13.89 for the half-year period.
Adline Chem Lab Limited's Company Secretary Akshita Khandelwal Resigns Due to Personal ReasonsAug 14, 2025
Akshita Khandelwal has resigned from her position as Company Secretary, Compliance Officer, and Key Managerial Personnel of Adline Chem Lab Limited, effective from the close of business on August 14, 2025. The resignation was attributed to personal and unavoidable reasons, with no other material reasons cited for her departure. The company has informed the stock exchange of this change in key personnel as required under regulatory obligations.
Adline Chem Lab Limited Approves Quarterly Financial Results for Quarter Ended June 30, 2025Aug 12, 2025
Adline Chem Lab Limited's Board of Directors approved the unaudited standalone financial results for the quarter ended June 30, 2025, during a meeting held on August 12, 2025. The board noted the Limited Review Report from statutory auditors, which contained no qualifications or modifications. The company also acknowledged a SEBI circular regarding a special window for re-lodgement of transfer requests for physical shares under the Ease of Doing Investments initiative. The financial results were prepared in accordance with Indian Accounting Standards and were reviewed and recommended by the audit committee.
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,782.00 | #1 4,27,561.49 | 40.68 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 71.49 | |
6,390.50 | 1,69,647.70 | 69.05 | 9,712.00 | 18.67 | 2,191 | 35.10 | 47.34 | |
3,687.30 | 1,24,794.99 | 58.80 | 11,539.40 | 6.99 | 1,911 | 30.46 | 54.89 | |
1,517.90 | 1,22,608.99 | 22.73 | 28,409.50 | 7.12 | 5,291 | 3.71 | 48.01 | |
1,247.40 | 1,04,109.72 | #1 18.15 | 33,741.20 | 16.73 | 5,725 | -0.38 | 53.56 | |
926.35 | 93,212.49 | 18.56 | 23,511.00 | 18.55 | 4,615 | 34.60 | 33.23 | |
2,032.60 | 92,839.92 | 21.34 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 58.77 | |
2,242.00 | 92,540.45 | 52.05 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 32.96 | |
1,210.70 | 70,317.65 | 20.70 | 32,345.60 | 9.43 | 3,484 | 3.81 | 63.26 | |
5,694.00 | 68,080.31 | 28.29 | 13,458.30 | 3.70 | 2,216 | 10.98 | 60.35 |
Growth Rate
Revenue Growth
-
Net Income Growth
-66.67 %
Cash Flow Change
-35.29 %
ROE
-55.33 %
ROCE
-662.63 %
EBITDA Margin (Avg.)
-99.99 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 19 | 18 | 21 | 23 | 22 | 8 | 6 | 5 | 0 | 0 | 0 |
| Fixed Assets | 10 | 10 | 13 | 13 | 12 | 5 | 4 | 4 | 0 | 0 | 0 |
| Current Assets | 7 | 7 | 8 | 11 | 10 | 3 | 2 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8 | 8 | 8 | 11 | 10 | 3 | 2 | 0 | 0 | 0 | 0 |
| Total Liabilities | 19 | 18 | 21 | 23 | 22 | 8 | 6 | 5 | 0 | 0 | 0 |
| Current Liabilities | 6 | 7 | 10 | 12 | 15 | 4 | 3 | 2 | 1 | 1 | 0 |
| Non Current Liabilities | 6 | 5 | 4 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| Total Equity | 7 | 7 | 7 | 7 | 7 | 3 | 2 | 3 | -2 | -1 | -2 |
| Reserve & Surplus | 1 | 1 | 1 | 1 | 1 | -3 | -4 | -3 | -7 | -7 | -7 |
| Share Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | -0 | -0 | 2 | -2 | -0 | -0 | 0 | 0 | 0 | 0 |
| Investing Activities | -2 | -0 | -3 | -0 | -0 | 11 | 0 | 0 | 0 | 0 | 0 |
| Operating Activities | 0 | 1 | 3 | 1 | -1 | -11 | -0 | 0 | 0 | -0 | -0 |
| Financing Activities | 2 | -1 | 1 | 1 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 31.46 % | 31.46 % | 30.45 % | 30.17 % | 30.17 % | 30.17 % | 28.24 % | 28.24 % | 28.24 % | 28.24 % | 28.24 % | 28.24 % | 29.61 % | 29.61 % | 29.61 % | 29.61 % | 29.61 % | 29.61 % | 29.61 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 58.27 % | 58.27 % | 59.27 % | 59.28 % | 59.29 % | 59.29 % | 61.25 % | 61.51 % | 61.51 % | 61.52 % | 61.53 % | 61.63 % | 60.29 % | 60.30 % | 60.32 % | 60.15 % | 60.13 % | 60.16 % | 60.16 % |
| Others | 10.28 % | 10.28 % | 10.28 % | 10.55 % | 10.54 % | 10.54 % | 10.52 % | 10.25 % | 10.25 % | 10.24 % | 10.23 % | 10.14 % | 10.10 % | 10.09 % | 10.07 % | 10.24 % | 10.26 % | 10.23 % | 10.23 % |
| No of Share Holders | 18,705 | 18,704 | 18,704 | 18,700 | 18,695 | 18,689 | 18,686 | 18,678 | 18,670 | 18,661 | 18,638 | 18,628 | 18,595 | 18,583 | 18,536 | 18,509 | 18,514 | 18,481 | 18,481 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 Sept 2021 |  Change Of Name | NA | 30 Sept 2021 | 0.00 | 0.00 |
| 27 Sept 2024 |  Annual General Meeting | NA | 27 Sept 2024 | 18.01 | 20.00 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 26.01 | 24.99 |
| 16 Jan 2025 |  Extraordinary General Meeting | NA | 16 Jan 2025 | 19.25 | 20.09 |
| 04 Feb 2025 | Quarterly Result Announcement | NA | 04 Feb 2025 | 19.10 | 18.00 |
| 09 May 2025 | Quarterly Result Announcement | NA | 09 May 2025 | 12.82 | 13.07 |
| 22 Jul 2025 | Annual General Meeting | NA | 22 Jul 2025 | 16.74 | 16.46 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 15.64 | 17.24 |
| 12 Nov 2025 | Quarterly Result Announcement | NA | 12 Nov 2025 | 14.89 | 13.45 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication
7 days ago
7 days agoAnnouncement under Regulation 30 (LODR)-Resignation of Chairman and Managing Director8 days ago
8 days agoAnnouncement under Regulation 30 (LODR)-Resignation of Director8 days ago
8 days agoUnaudited Standalone Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 20258 days ago
8 days agoBoard Meeting Outcome for Board Meeting Outcome For Unaudited Standalone Financial Results Of The Company For The Quarter And Half Year Ended On 30Th September 20258 days ago
8 days agoBoard Meeting Intimation for Consideration And Approval Of The Unaudited Standalone Financial Results For The Quarter And Half Year Ended September 30 2025.Nov 05, 2025
Nov 05, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 15, 2025
Oct 15, 2025Closure of Trading WindowSep 30, 2025
Sep 30, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerAug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Aug 14, 2025Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30 2025Aug 12, 2025
Aug 12, 2025Board Meeting Outcome for Board Meeting Outcome For Outcome Of Board Meeting For Unaudited Standalone Financial Results Of The Company For The Quarter Ended June 30 2025Aug 12, 2025
Aug 12, 2025Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone Financial Results For The Quarter Ended On 30Th June 2025. Aug 05, 2025
Aug 05, 2025Scrutinizer"S ReportJul 23, 2025
Jul 23, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMJul 22, 2025
Jul 22, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2025
Jul 15, 2025Reg. 34 (1) Annual Report.Jun 28, 2025
Jun 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 28, 2025
Jun 28, 2025AGM OF THE COMPANY SCHEDULED TO BE HELD ON TUESDAY 22ND JULY 2025 AT 02:00 P.M.Jun 27, 2025
Jun 27, 2025Intimation Of Record Date Pursuant To Regulation 42 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Jun 27, 2025
Jun 27, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Rescheduled Of Annual General MeetingJun 20, 2025
Jun 20, 2025Appointment Of Secretarial Auditor.Jun 13, 2025
Jun 13, 2025Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of AssociationJun 13, 2025
Jun 13, 2025Announcement under Regulation 30 (LODR)-Change in DirectorateJun 13, 2025
Jun 13, 2025Appointment Of CFOJun 13, 2025
Jun 13, 2025Announcement under Regulation 30 (LODR)-Change in Registered Office AddressJun 13, 2025
Jun 13, 2025Appointment of Company Secretary and Compliance OfficerJun 13, 2025
Jun 13, 2025Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Jun 13, 2025
Jun 13, 2025Board Meeting Outcome for Outcome Of Board MeetingJun 13, 2025
Jun 13, 2025Board Meeting Intimation for The Meeting Of The Board Of Directors Pursuant To Regulation 29 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Jun 06, 2025
Jun 06, 2025Revised Outcome Of The Board MeetingMay 20, 2025
May 20, 2025Submission Of Readable CopyMay 13, 2025
May 13, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 12, 2025
May 12, 2025Financial Results For March 31 2025May 09, 2025
May 09, 2025Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. 09.05.2025May 09, 2025
May 09, 2025Board Meeting Intimation for The Quarter And Financial Year Ended March 31 2025May 02, 2025
May 02, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 02, 2025
May 02, 2025Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerApr 22, 2025
Apr 22, 2025Announcement under Regulation 30 (LODR)-Change in ManagementApr 12, 2025
Apr 12, 2025Board Meeting Outcome for Appointment Of Additional DirectorsApr 12, 2025
Apr 12, 2025Non-Applicability Of Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 11, 2025
Apr 11, 2025Board Meeting Intimation for Appointment Of Additional Directors.Apr 09, 2025
Apr 09, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Apr 08, 2025Closure of Trading WindowMar 24, 2025
Mar 24, 2025Integrated Filing (Financial)Feb 12, 2025
Feb 12, 2025Disclosure Regarding Submission Of Application Under Regulation 31A Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Re-Classification Of PromotersFeb 10, 2025
Feb 10, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 05, 2025
Feb 05, 2025Results For Quarter And Nine Months Ended On 31St December 2024.Feb 04, 2025
Feb 04, 2025Board Meeting Outcome for Outcome Of Board Of Directors Meeting Of Adline Chem Lab Limited Held On 4Th February 2025Feb 04, 2025
Feb 04, 2025Technical Indicators
RSI(14)
Neutral 22.56
ATR(14)
Less Volatile 0.74
STOCH(9,6)
Oversold 0.48
STOCH RSI(14)
Oversold 0.00
MACD(12,26)
Bearish -0.53
ADX(14)
Strong Trend 29.40
UO(9)
Bullish 9.93
ROC(12)
Downtrend And Accelerating -40.41
WillR(14)
Oversold -100.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
